Bayer AG BAYN-DE:XETRA

*Data is delayed | EUR
Last | 08/12/22 CEST
54.15quote price arrow up+2.47 (+4.78%)
Volume
4,532,250
52 week range
43.91 - 67.99
Loading...
  • Open51.81
  • Day High54.29
  • Day Low51.81
  • Prev Close51.68
  • 52 Week High67.99
  • 52 Week High Date04/13/22
  • 52 Week Low43.91
  • 52 Week Low Date12/06/21

Key Stats

  • Market Cap13,390.44M
  • Shares Out982.42M
  • 10 Day Average Volume3.23M
  • Dividend2.00
  • Dividend Yield3.69%
  • Beta-
  • YTD % Change15.21

KEY STATS

  • Open51.81
  • Day High54.29
  • Day Low51.81
  • Prev Close51.68
  • 52 Week High67.99
  • 52 Week High Date04/13/22
  • 52 Week Low43.91
  • 52 Week Low Date12/06/21
  • Market Cap13,390.44M
  • Shares Out982.42M
  • 10 Day Average Volume3.23M
  • Dividend2.00
  • Dividend Yield3.69%
  • Beta-
  • YTD % Change15.21

RATIOS/PROFITABILITY

  • EPS (TTM)4.32
  • P/E (TTM)12.53
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date05/02/2022
  • Div Amount2.00
  • Split Date-
  • Split Factor-

Content From Our Affiliates

Profile

MORE
Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Company is focusing on their oncology platform for Targeted Alpha Therapies for treating...
Wolfgang Nickl
Chief Financial Officer, Member of the Management Board
Address
Kaiser-Wilhelm-Allee 1
Leverkusen
51373
Germany